Neuromolecular Medicine

Journal Title：Neuromolecular Medicine

NeuroMolecular Medicine publishes cutting-edge original research articles and critical reviews on the molecular and biochemical basis of neurological disorders. Studies range from genetic analyses of human populations to animal and cell culture models of neurological disorders. Emerging findings concerning the identification of genetic aberrancies and their pathogenic mechanisms at the molecular and cellular levels will be included. Also covered are experimental analyses of molecular cascades involved in the development and adult plasticity of the nervous system, in neurological dysfunction, and in neuronal degeneration and repair. NeuroMolecular Medicine encompasses basic research in the fields of molecular genetics, signal transduction, plasticity, and cell death. The information published in NEMM will provide a window into the future of molecular medicine for the nervous system.

《神经分子医学》发表关于神经系统疾病的分子和生化基础的前沿原创研究文章和评论。研究范围从人类群体的遗传分析到神经系统疾病的动物和细胞培养模型。将包括有关在分子和细胞水平上识别遗传异常及其致病机制的新发现。还涵盖了涉及神经系统发育和成人可塑性、神经功能障碍以及神经元退化和修复的分子级联的实验分析。《神经分子医学》涵盖分子遗传学、信号转导、可塑性和细胞死亡领域的基础研究。NEMM 上发表的信息将为神经系统分子医学的未来提供一个窗口。

Neuromolecular Medicine创刊于2002年，由Springer US出版商出版，收稿方向涵盖医学 - 神经科学全领域，此期刊水平偏中等偏靠后，在所属细分领域中专业影响力一般，过审相对较易，如果您文章质量佳，选择此期刊，发表机率较高。平均审稿速度 12周，或约稿 ，影响因子指数3.3，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。